Vanda Pharmaceuticals
VNDA
#7861
Rank
$0.31 B
Marketcap
$5.39
Share price
3.65%
Change (1 day)
11.36%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -$0.13 Billion USD

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are $0.21 Billion USD. In 2024 the company made an earning of -$40.66 Million USD a decrease over its 2023 earnings that were of -$13.96 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$0.13 Billion197.82%
2024 -$40.66 Million191.43%
2023 -$13.96 Million-320.45%
2022 $6.32 M-84.99%
2021 $42.16 M54.8%
2020 $27.23 M19.42%
2019 $22.81 M4.93%
2018 $21.73 M-228.6%
2017 -$16.91 Million-8.98%
2016 -$18.58 Million-53.79%
2015 -$40.19 Million-30.18%
2014 -$57.56 Million173.08%
2013 -$21.08 Million-25.33%
2012 -$28.23 Million163.61%
2011 -$10.71 Million-221.15%
2010 $8.83 M-124.53%
2009 -$36.04 Million-29.44%
2008 -$51.07 Million-36.2%
2007 -$80.04 Million21.81%
2006 -$65.71 Million170.55%
2005 -$24.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
$16.41 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
$22.50 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$32.39 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$8.03 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$11.85 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-$2.81 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$23.09 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA